SWOG S1922

Primary Category:

Treatment Protocols

Disease Category:

Gastrointestinal, Small Bowel

Status:

New, Open

Randomized Phase II Selection Study of Ramucirumab and Paclitaxel Versus FOLFIRI in Refractory Small Bowel Adenocarcinoma

NCT#04205968